Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Sep 3

PMID 20808443

Citations 27

Authors

Heath A Elrod

Songqing Fan

Susan Muller

Georgia Z Chen

Lin Pan

Mourad Tighiouart

Dong M Shin

Fadlo R Khuri

Shi-Yong Sun

Affiliations

Soon will be listed here.

Abstract

Death receptor 5 (DR5) and caspase-8 are major components in the extrinsic apoptotic pathway. The alterations of the expression of these proteins during the metastasis of head and neck squamous cell carcinoma (HNSCC) and their prognostic impact have not been reported. The present study analyzes the expression of DR5 and caspase-8 by immunohistochemistry (IHC) in primary and metastatic HNSCCs and their impact on patient survival. Tumor samples in this study included 100 primary HNSCC with no evidence of metastasis, 100 primary HNSCC with lymph node metastasis (LNM) and 100 matching LNM. IHC analysis revealed a significant loss or downregulation of DR5 expression in primary tumors with metastasis and their matching LNM compared to primary tumors with no evidence of metastasis. A similar trend was observed in caspase-8 expression although it was not statistically significant. Downregulation of caspase-8 and DR5 expression was significantly correlated with poorly differentiated tumors compared to moderately and well differentiated tumors. Univariate analysis indicates that, in HNSCC with no metastasis, higher expression of caspase-8 significantly correlated with better disease-free survival and overall survival. However, in HNSCC with LNM, higher caspase-8 expression significantly correlated with poorer disease-free survival and overall survival. Similar results were also generated when we combined both DR5 and caspase-8. Taken together, we suggest that both DR5 and caspase-8 are involved in regulation of HNSCC metastasis. Our findings warrant further investigation on the dual role of caspase-8 in cancer development.

Citing Articles

Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication.

Goldmacher V, Gershteyn I, Kovtun Y Antib Ther. 2025; 7(4):351-360.

PMID: 40061208 PMC: 11887037. DOI: 10.1093/abt/tbae029.

Caspase-8 in inflammatory diseases: a potential therapeutic target.

Zhang W, Zhu C, Liao Y, Zhou M, Xu W, Zou Z Cell Mol Biol Lett. 2024; 29(1):130.

PMID: 39379817 PMC: 11463096. DOI: 10.1186/s11658-024-00646-x.

Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer.

Chen Z, Vallega K, Wang D, Quan Z, Fan S, Wang Q J Exp Med. 2024; 221(11).

PMID: 39297884 PMC: 11413468. DOI: 10.1084/jem.20240435.

Death receptor 5 promotes tumor progression in gastric cancer.

Chen J, Li L, Huangfu L, Du H, Ji X, Xing X FEBS Open Bio. 2023; 13(12):2375-2388.

PMID: 37879960 PMC: 10699099. DOI: 10.1002/2211-5463.13725.

Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

Bravo Perina L, Gomes I, Alcantara Pelloso A, Silva V, Arantes L, Melendez M Sci Rep. 2023; 13(1):18023.

PMID: 37865660 PMC: 10590400. DOI: 10.1038/s41598-023-44888-9.

References

Xu L, Deng X . Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J Biol Chem. 2005; 281(7):4457-66. DOI: 10.1074/jbc.M510721200. View

Barbero S, Mielgo A, Torres V, Teitz T, Shields D, Mikolon D . Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis. Cancer Res. 2009; 69(9):3755-63. PMC: 2684981. DOI: 10.1158/0008-5472.CAN-08-3937. View

Wajant H, Pfizenmaier K, Scheurich P . TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy. Apoptosis. 2002; 7(5):449-59. DOI: 10.1023/a:1020039225764. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

Vakkala M, Paakko P, Soini Y . Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer. 1999; 81(4):592-9. PMC: 2362889. DOI: 10.1038/sj.bjc.6690735. View

Duiker E, van der Zee A, de Graeff P, Boersma-van Ek W, Hollema H, de Bock G . The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer. Gynecol Oncol. 2009; 116(3):549-55. DOI: 10.1016/j.ygyno.2009.09.014. View

Shivapurkar N, Toyooka S, Eby M, Huang C, Sathyanarayana U, Cunningham H . Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther. 2002; 1(1):65-9. DOI: 10.4161/cbt.1.1.45. View

van Geelen C, Westra J, de Vries E, Boersma-van Ek W, Zwart N, Hollema H . Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients. J Clin Oncol. 2006; 24(31):4998-5004. DOI: 10.1200/JCO.2006.06.8809. View

Xu B, Zhou Z, Li Y, Wang L, Yang L, Zhou B . Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer. Oncology. 2008; 74(3-4):229-36. DOI: 10.1159/000151392. View

10.

Teitz T, Wei T, Valentine M, Vanin E, Grenet J, Valentine V . Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 2000; 6(5):529-35. DOI: 10.1038/75007. View

11.

Maduro J, Noordhuis M, ten Hoor K, Pras E, Arts H, Eijsink J . The prognostic value of TRAIL and its death receptors in cervical cancer. Int J Radiat Oncol Biol Phys. 2009; 75(1):203-11. DOI: 10.1016/j.ijrobp.2009.03.071. View

12.

Fulda S, Poremba C, Berwanger B, Hacker S, Eilers M, Christiansen H . Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma. Cancer Res. 2006; 66(20):10016-23. DOI: 10.1158/0008-5472.CAN-05-4079. View

13.

Lu L, Zavitz C, Chen B, Kianpour S, Wan Y, Stampfli M . Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol. 2007; 178(2):936-43. DOI: 10.4049/jimmunol.178.2.936. View

14.

Xu L, Deng X . Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion. J Biol Chem. 2004; 279(51):53683-90. DOI: 10.1074/jbc.M409889200. View

15.

Soung Y, Lee J, Kim S, Sung Y, Park W, Nam S . Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene. 2004; 24(1):141-7. DOI: 10.1038/sj.onc.1208244. View

16.

Senft J, Helfer B, Frisch S . Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res. 2007; 67(24):11505-9. DOI: 10.1158/0008-5472.CAN-07-5755. View

17.

Ashkenazi A . Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 2008; 19(3-4):325-31. DOI: 10.1016/j.cytogfr.2008.04.001. View

18.

Zhuang L, Lee C, Scolyer R, McCarthy S, Zhang X, Thompson J . Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Hum Pathol. 2006; 37(10):1286-94. DOI: 10.1016/j.humpath.2006.04.026. View

19.

Helfer B, Boswell B, Finlay D, Cipres A, Vuori K, Kang T . Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res. 2006; 66(8):4273-8. DOI: 10.1158/0008-5472.CAN-05-4183. View

20.

Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin D . Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer. 2008; 113(1):97-107. DOI: 10.1002/cncr.23557. View